Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score

Sudden cardiac death (SCD) is the most life-threating complication of hypertrophic cardiomyopathy. Guidelines of the European Society of Cardiology (ESC) suggest the implantation of an implantable cardioverter defibrillator in primary prevention according to a 5-year risk SCD score ≥6%. The aim of t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2019-10, Vol.124 (8), p.1286-1292
Hauptverfasser:	Todiere, Giancarlo, Nugara, Cinzia, Gentile, Giovanni, Negri, Francesco, Bianco, Francesco, Falletta, Calogero, Novo, Giuseppina, Di Bella, Gianluca, De Caterina, Raffaele, Zachara, Elisabetta, Re, Federica, Clemenza, Francesco, Sinagra, Gianfranco, Emdin, Michele, Aquaro, Giovanni Donato
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiac arrhythmia Cardiology Cardiomyopathy Cardiomyopathy, Hypertrophic - complications Cardiomyopathy, Hypertrophic - diagnosis Cardiomyopathy, Hypertrophic - physiopathology Confidence intervals Contrast Media - pharmacology Death, Sudden, Cardiac - epidemiology Death, Sudden, Cardiac - etiology Defibrillators Diuretics Electrocardiography Female Follow-Up Studies Gadolinium Gadolinium - pharmacology Heart Heart Ventricles - diagnostic imaging Heart Ventricles - physiopathology Humans Hypertension Implantation Incidence Investigations Italy - epidemiology Magnetic resonance Magnetic Resonance Imaging, Cine - methods Male Males Middle Aged Myocardium - pathology Population Prognosis Questionnaires Retrospective Studies Risk Risk Assessment - methods Risk Factors ROC Curve Survival Rate - trends Tachycardia Variance analysis Ventricle Ventricular Function, Left - physiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Sudden cardiac death (SCD) is the most life-threating complication of hypertrophic cardiomyopathy. Guidelines of the European Society of Cardiology (ESC) suggest the implantation of an implantable cardioverter defibrillator in primary prevention according to a 5-year risk SCD score ≥6%. The aim of the study is to evaluate the prognostic role of late gadolinium enhancement (LGE) in patients with a 5-year risk SCD score
ISSN:	0002-9149 1879-1913
DOI:	10.1016/j.amjcard.2019.07.023